A phase II trial of temozolomide as a 6-week, continuous, oral schedule in patients with advanced soft tissue sarcoma: A study by the spanish group for research on sarcomas

1. Garcia Del Muro, X.
2. Lopez-Pousa, A.
3. Martin, J.
4. Buesa, J.M.
5. Martinez-Trufero, J.
6. Casado, A.
7. Poveda, A.
8. Cruz, J.
9. Bover, I.
10. Maurel, J.